Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
about
Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and managementLong QT Syndrome: An Emerging Role for Inflammation and ImmunityVentricular repolarization measures for arrhythmic risk stratificationInterventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.Genetic screening in sudden cardiac death in the young can save future livesIncidence of Sustained Ventricular Tachycardia in Patients with Prolonged QTc After the Administration of Azithromycin: A Retrospective Study.Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis.Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.Post-acute management of the acquired long QT syndrome.5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.Is There a Role for Genetics in the Prevention of Sudden Cardiac Death?Provider Response to QTc Prolongation on Standard 12-Lead EKG: Do We Notice or Do We Care?Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.The prevalence of long QT interval in post-operative intensive care unit patients.Association between a prolonged corrected QT interval and outcomes in patients in a medical Intensive Care Unit.Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents.Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics.Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluationPredictors of mortality in high-risk patients with QT prolongation in a community hospital.QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study.Providers' Response to Clinical Decision Support for QT Prolonging Drugs.QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications.Association between a frailty index based on common laboratory tests and QTc prolongation in older adults: the Rugao Longevity and Ageing Study.Incidence and outcomes of long QTc in acute medical admissions
P2860
Q26747032-E27D3B15-AA54-4177-92D4-656221F201B6Q26769710-8F3464FE-C0CC-4ECE-8646-F45777566F15Q26769982-8A20D25F-A6DD-4AAA-8F43-D8F7AE67F12AQ27687546-14673BA2-5EEC-4F20-93D9-83664BCF118DQ36418252-9AF8F4E1-5141-47E1-8FDD-D2BE2B1A24C9Q36460505-EE2253B4-4911-4332-9EA9-8F1799F5FF37Q36761496-C64B6068-7D58-4DC2-971C-3D41387BB289Q36982588-136C0CCE-FA82-45C8-B5DF-F85A43A13E4EQ37211037-1053DE2B-A145-40C9-AD4E-C3B9DD8E9CBBQ38201702-28BB0E54-0581-4AB2-8FAF-424D15509889Q38246665-FDDD0618-97CF-4D62-B89A-92591661432AQ38856035-0D22C5CC-EDBA-4B95-BBC3-444CF8328AAFQ38954516-06FFDACF-8E0B-4145-8ABF-1AFECAF59F13Q38965997-7CB6284C-5432-4CCA-B969-12C7DDCA928AQ41591297-2175F9E5-E958-49AA-B52D-8CBEF2C31A1FQ42409546-E11CE62F-E2F6-4137-985B-360701DF4E7AQ43463394-745FB3B6-5F0F-4DD5-AE35-B7A145268F41Q45347471-B3894D16-991D-4F7A-B5C6-C0E7BB553D82Q46933817-98632903-61A9-4020-9B0D-A1577E6D7219Q47608205-17E3A610-CCCF-436A-817F-B08CDEC3F26CQ48248716-91BC0092-82F4-40B9-A01F-97FC5795ABEAQ50230057-96AD24AC-16B6-44AE-873D-8F6162E10C29Q55249234-D0E9C959-9CDA-4057-A311-B719A4350020Q55502584-0A1CDFDF-CC0C-47F6-8F36-50030A85F5E4Q58697738-68AE8545-CEE2-4DB6-940E-0FAEF138D10B
P2860
Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prevalence of QT interval prol ...... emic medical center in the US.
@en
type
label
Prevalence of QT interval prol ...... emic medical center in the US.
@en
prefLabel
Prevalence of QT interval prol ...... emic medical center in the US.
@en
P2093
P2860
P1433
P1476
Prevalence of QT interval prol ...... emic medical center in the US.
@en
P2093
Brian R Overholser
Heather A Wroblewski
James E Tisdale
Joanna R Kingery
Richard J Kovacs
Tate N Trujillo
P2860
P304
P356
10.2165/11598160-000000000-00000
P577
2012-06-01T00:00:00Z
P6179
1043467288